Article Information
History
- November 2, 2025.
Article Versions
- You are currently viewing Version 1 of this article (November 2, 2025 - 20:45).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nabasmita Talukdar, MS1,
- Zeshui Yu, PharmD2,
- Zheng Zeng, MISM3,
- Xiaodan Zhang, MA4,
- Ying Lu, PhD5,
- Dimitri F. Joseph, MS6,
- Dmitry Leshchiner, MD4,
- Hui Wang, PhD3 and
- Bin Chen, PhD1,4,6
- 1Department of Biostatistics and Epidemiology, Michigan State University
- 2Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy
- 3Lumbrita LLC
- 4Department of Pediatrics and Human Development, Michigan State University
- 5Department of Biomedical Data Science, Stanford University School of Medicine
- 6Department of Pharmacology and Toxicology, Michigan State University
- Corresponding Author:
Bin Chen, PhD, Department of Pediatrics and Human Development, Department of Pharmacology and Toxicology, Michigan State University, Grand Rapids, MI 49503, United States, (chenbi12{at}msu.edu) Co-Corresponding Author:
Hui Wang, PhD, Lumbrita LLC, 12291 Titus Ave, Saratoga, CA 95070, United States, (hwang{at}lumbrita.com)
Posted November 02, 2025.
Characterization of Liver Metastasis Risk and Timing in Pancreatic Cancer Patients Using Electronic Health Records
